Stock Analysis

Analysts Are Upgrading OssDsign AB (publ) (STO:OSSD) After Its Latest Results

OM:OSSD
Source: Shutterstock

OssDsign AB (publ) (STO:OSSD) defied analyst predictions to release its full-year results, which were ahead of market expectations. It looks like a positive result overall, with revenues of kr134m beating forecasts by 3.6%. Statutory losses of kr0.50 per share were 3.6% smaller than the analysts expected, likely helped along by the higher revenues. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on OssDsign after the latest results.

View our latest analysis for OssDsign

earnings-and-revenue-growth
OM:OSSD Earnings and Revenue Growth February 7th 2025

Following the latest results, OssDsign's five analysts are now forecasting revenues of kr184.9m in 2025. This would be a major 38% improvement in revenue compared to the last 12 months. Losses are predicted to fall substantially, shrinking 22% to kr0.40. Yet prior to the latest earnings, the analysts had been forecasting revenues of kr176.0m and losses of kr0.40 per share in 2025.

The consensus price target rose 8.5% to kr12.75, with the analysts encouraged by the improved revenue outlook even though the company remains lossmaking. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. The most optimistic OssDsign analyst has a price target of kr14.00 per share, while the most pessimistic values it at kr12.00. Even so, with a relatively close grouping of estimates, it looks like the analysts are quite confident in their valuations, suggesting OssDsign is an easy business to forecast or the the analysts are all using similar assumptions.

Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. We can infer from the latest estimates that forecasts expect a continuation of OssDsign'shistorical trends, as the 38% annualised revenue growth to the end of 2025 is roughly in line with the 42% annual growth over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to see their revenues grow 18% per year. So although OssDsign is expected to maintain its revenue growth rate, it's definitely expected to grow faster than the wider industry.

The Bottom Line

The most important thing to take away is that the analysts reconfirmed their loss per share estimates for next year. Pleasantly, they also upgraded their revenue estimates, and their forecasts suggest the business is expected to grow faster than the wider industry. There was also a nice increase in the price target, with the analysts clearly feeling that the intrinsic value of the business is improving.

With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have estimates - from multiple OssDsign analysts - going out to 2027, and you can see them free on our platform here.

That said, it's still necessary to consider the ever-present spectre of investment risk. We've identified 1 warning sign with OssDsign , and understanding this should be part of your investment process.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About OM:OSSD

OssDsign

Designs, manufactures, and sells implants and material technology for bone regeneration in Sweden, Germany, the United States, the United Kingdom, rest of Europe, and internationally.

High growth potential with excellent balance sheet.

Community Narratives

Priced for AI perfection - cracks are emerging
Fair Value US$90.15|42.74% overvalued
ChadWisperer
ChadWisperer
Community Contributor
NVDA Market Outlook
Fair Value US$341.12|62.277% undervalued
NateF
NateF
Community Contributor
Karoon Energy (ASX:KAR) - Buy Baby Buy 🚀
Fair Value AU$5.10|69.118% undervalued
StockMan
StockMan
Community Contributor